Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Biotechnology
Intuitive Surgical Gets New Price Targets After Earnings Beat
The surgical equipment manufacturer's second quarter report surprised analysts, setting Intuitive up for a strong second half.
Prepare for Volatility Around Biogen Ahead of Alzheimer's Presentation: Leerink
Positive readings from the biotech giant's Alzheimer's drug could drive the stock to as high as $393.
5 Big Biotech Stories to Watch
The biotech and pharmaceutical industries have had some big news in recent weeks. Here's what you should know to stay up-to-date.
3 'Strong Buy' Healthcare Stocks Poised to Surge
Here are the top healthcare bets ticking all the boxes for analysts.
Indivior Soars on Court Ruling Blocking Sales of Rival's Generic Opioid Drug
The drug company received a preliminary injunction blocking Dr. Reddy's Laboratories from selling its opioid treatment drug.
OncoCyte Surges on 'Encouraging' Results for Diagnostic Test for Cancer
The company sees the market for lung cancer detection as being worth $4.7 billion annually.
Market Madness: Twitter Slumps and Biotech is Going for an M&A Record
Let's review what happened on Monday.
Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD
The deal is part of Axovant's strategy to focus on neurological gene therapies.
Biogen Sparks Hope on Treating Alzheimer's Disease: Everything You Must Know
Biogen delivered promising results on a new Alzheimer's disease treatment. And investors rewarded the company accordingly.
Biogen Shares Soar on Positive Alzheimer's Drug Results
The company's drug showed promising results versus a placebo in a Phase 2 trial.